Sphingosine Kinase (SK) Inhibitors

Sphingosine Kinase (SK) inhibitors are a class of innovative compounds that have gained significant attention in the field of biology due to their potential therapeutic applications SK is an enzyme that plays a crucial role in regulating sphingosine-1-phosphate (S1P) a lipid mediator involved in various cellular processes By inhibiting the activity of SK these inhibitors offer the potential to modulate S1P levels and subsequently impact cellular signaling pathways This targeted modulation holds promise for the development of novel treatments in areas such as cancer inflammation and immune disorders Our company specializes in providing a comprehensive range of highly potent and selective SK inhibitors for research and drug discovery purposes

Catalog Number	Chemical Name	CAS #	Price
EI-0096	ABC294640	915385-81-8	Online Inquiry
EI-2045	Sphingosine Kinase Inhibitor, SKI-I	306301-68-8	Online Inquiry
EI-2046	Sphingosine Kinase Inhibitor, SKI-II	312636-16-1	Online Inquiry

Application

Sphingosine Kinase (SK) inhibitors have numerous applications in the field of biomedical research and drug development These inhibitors are commonly used to study the role of sphingosine kinase an enzyme involved in the regulation of cell proliferation migration and survival

In cancer research SK inhibitors have shown promise as potential anti-cancer agents By blocking the activity of sphingosine kinase these inhibitors can disrupt cell signaling pathways and inhibit cancer cell growth This makes them valuable tools for studying the mechanisms of cancer progression and for developing targeted therapies

Furthermore SK inhibitors have also shown potential in treating inflammatory and autoimmune diseases Sphingosine-1-phosphate (S1P) the product of sphingosine kinase activity is known to play a role in the immune response By inhibiting SK these inhibitors can modulate S1P levels and regulate immune cell functions This opens up the possibility of developing novel treatments for conditions such as multiple sclerosis and rheumatoid arthritis

In summary the applications of Sphingosine Kinase (SK) inhibitors are diverse and hold great potential in advancing our understanding of disease mechanisms and developing effective treatments

Please note that all services are for research use only. Not intended for any clinical use.

Sphingosine Kinase (SK) Inhibitors